Groundbreaking Medical News Impacts Millions of Patients Globally

In recent years, pulmonary embolism has been a disease that primarily affects young people, particularly women, with the peak incidence occurring between the ages of 30-40. However, it can also occur at later ages. Patients with pulmonary embolism are categorized based on function levels and risk levels, ranging from 1 (highest function) to 4 (lowest function).

For a decade, there were no advancements in the treatment of pulmonary embolism, with existing treatments mainly focused on alleviating symptoms. This was until the American Food and Drug Administration (FDA) recently approved a groundbreaking drug called sotatracept, the first of its kind to treat the disease itself, rather than just symptoms.

Sotatracept works by inhibiting a unique component called “activin,” which changes the mechanism of the cells that drive the disease. This approval marks a significant improvement for patients with pulmonary hypertension, offering better survival rates and reducing the risk of worsening events or death by approximately 84%.

According to Prof. Mordechai Kramer, director of the pulmonary department at Blinson Hospital, sotatracept provides new hope for patients who have not responded well to existing treatments. The Ministry of Health usually approves drugs that have been approved by the FDA after reviewing the research findings submitted by the company. Sotatracept is expected to become available in pharmacies soon and will be an important addition to current treatment options for this serious and life-threatening disease.

By Sophia Gonzalez

As a content writer at, I am dedicated to crafting engaging stories that captivate our readers. With a knack for turning complex topics into accessible and compelling narratives, I weave words together to inform and inspire. My passion lies in delivering accurate and thought-provoking content that keeps our audience informed and entertained. From breaking news stories to in-depth features, I strive to bring a fresh perspective to every piece I create. Join me on this journey of exploration and discovery through the power of words at

Leave a Reply